BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35122055)

  • 1. Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells.
    Zhai K; Huang Z; Huang Q; Tao W; Fang X; Zhang A; Li X; Stark GR; Hamilton TA; Bao S
    Nat Cancer; 2021 Nov; 2(11):1136-1151. PubMed ID: 35122055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism.
    Stern AL; Ghura S; Gannon PJ; Akay-Espinoza C; Phan JM; Yee AC; Vassar R; Gelman BB; Kolson DL; Jordan-Sciutto KL
    J Neurosci; 2018 May; 38(18):4288-4300. PubMed ID: 29632166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer's Disease.
    Naushad M; Durairajan SSK; Bera AK; Senapati S; Li M
    Planta Med; 2019 Nov; 85(17):1316-1325. PubMed ID: 31618777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory effect of chitosan oligosaccharides on β-site amyloid precursor protein cleaving enzyme 1 (BACE1) in HEK293 APPswe cells.
    Dai X; Chang P; Li X; Gao Z; Sun Y
    Neurosci Lett; 2018 Feb; 665():80-85. PubMed ID: 29175631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling.
    Peng P; Zhu H; Liu D; Chen Z; Zhang X; Guo Z; Dong M; Wan L; Zhang P; Liu G; Zhang S; Dong F; Hu F; Cheng F; Huang S; Guo D; Zhang B; Yu X; Wan F
    Theranostics; 2022; 12(9):4221-4236. PubMed ID: 35673564
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased TNFR1 expression and signaling in injured peripheral nerves of mice with reduced BACE1 activity.
    Liu L; Fissel JA; Tasnim A; Borzan J; Gocke A; Calabresi PA; Farah MH
    Neurobiol Dis; 2016 Sep; 93():21-7. PubMed ID: 27080468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the β secretase BACE1 for Alzheimer's disease therapy.
    Yan R; Vassar R
    Lancet Neurol; 2014 Mar; 13(3):319-29. PubMed ID: 24556009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-specific deletion of BACE1 does not enhance macrophage recruitment to the injured peripheral nerve.
    Fissel JA; Farah MH
    J Neuroimmunol; 2020 Dec; 349():577423. PubMed ID: 33074142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer's Disease.
    Shah H; Patel A; Parikh V; Nagani A; Bhimani B; Shah U; Bambharoliya T
    CNS Neurol Disord Drug Targets; 2020; 19(3):184-194. PubMed ID: 32452328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system.
    Farah MH; Pan BH; Hoffman PN; Ferraris D; Tsukamoto T; Nguyen T; Wong PC; Price DL; Slusher BS; Griffin JW
    J Neurosci; 2011 Apr; 31(15):5744-54. PubMed ID: 21490216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A series of molecular modeling techniques to reveal selective mechanisms of inhibitors to β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) and β-site amyloid precursor protein cleaving enzyme 2 (BACE2).
    Li S; Zhao H; Li J; Hao J; Yu H
    J Biomol Struct Dyn; 2021 May; 39(8):2824-2837. PubMed ID: 32276567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the ectodomain shedding of the beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1).
    Hussain I; Hawkins J; Shikotra A; Riddell DR; Faller A; Dingwall C
    J Biol Chem; 2003 Sep; 278(38):36264-8. PubMed ID: 12857759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clec4g (LSECtin) interacts with BACE1 and suppresses Aβ generation.
    Kizuka Y; Kitazume S; Sato K; Taniguchi N
    FEBS Lett; 2015 Jun; 589(13):1418-22. PubMed ID: 25957769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer's disease mouse model.
    Shi Z; Hong Y; Zhang K; Wang J; Zheng L; Zhang Z; Hu Z; Han X; Han Y; Chen T; Yao Q; Cui H; Hong W
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2398-2407. PubMed ID: 28502705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPP-β Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer's Disease Models.
    Resende R; Ferreira-Marques M; Moreira P; Coimbra JRM; Baptista SJ; Isidoro C; Salvador JAR; Dinis TCP; Pereira CF; Santos AE
    J Alzheimers Dis; 2020; 76(4):1317-1337. PubMed ID: 32597812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Fat Diet Enhances β-Site Cleavage of Amyloid Precursor Protein (APP) via Promoting β-Site APP Cleaving Enzyme 1/Adaptor Protein 2/Clathrin Complex Formation.
    Maesako M; Uemura M; Tashiro Y; Sasaki K; Watanabe K; Noda Y; Ueda K; Asada-Utsugi M; Kubota M; Okawa K; Ihara M; Shimohama S; Uemura K; Kinoshita A
    PLoS One; 2015; 10(9):e0131199. PubMed ID: 26414661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation.
    Zhu BL; Long Y; Luo W; Yan Z; Lai YJ; Zhao LG; Zhou WH; Wang YJ; Shen LL; Liu L; Deng XJ; Wang XF; Sun F; Chen GJ
    Brain; 2019 Jan; 142(1):176-192. PubMed ID: 30596903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BACE1: the beta-secretase enzyme in Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
    Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
    Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.